Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Hack

Showing results (171-180 of 369) with videos related to

Pageof 37
Sort By:
Kidney International|January 1, 1995
Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejectionJ A Kummer, P C Wever, A M Kamp, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniaeM J Schultz, P Speelman, C E Hack, et al.
Journal of Clinical Pathology|December 29, 2000
Apolipoprotein H, a new mediator in the inflammatory changes ensuring in jeopardised human myocardiumH W Niessen, W K Lagrand, H J Rensink, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 1, 1996
Increased numbers of granzyme-B-expressing cytotoxic T-lymphocytes in the small intestine of HIV-infected patientsF Snijders, P C Wever, S A Danner, et al.
The Journal of Biological Chemistry|August 5, 1989
Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor)J H Nuijens, C C Huijbregts, A J Eerenberg-Belmer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Pro- and non-coagulant forms of non-cell-bound tissue factor in vivoK N Sturk-Maquelin, R Nieuwland, F P H T M Romijn, et al.
Agents and Actions. Supplements|January 1, 1992
Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patientsM Levi, C E Hack, J P de Boer, et al.
British Journal of Haematology|February 15, 2002
Complement activation plays a key role in the side-effects of rituximab treatmentL E van der Kolk, A J Grillo-López, J W Baars, et al.
Blood|December 15, 1990
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathwaysS J van Deventer, H R Büller, J W ten Cate, et al.
British Journal of Haematology|May 1, 1986
Chronic idiopathic and secondary neutropenia: clinical and serological investigationsJ P van der Veen, C E Hack, C P Engelfriet, et al.
Pageof 37

Showing results (171-180 of 369) with videos related to

Sort By:
Pageof 37
Kidney International|January 1, 1995
Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejectionJ A Kummer, P C Wever, A M Kamp, et al.
The Journal of Antimicrobial Chemotherapy|August 10, 2000
Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniaeM J Schultz, P Speelman, C E Hack, et al.
Journal of Clinical Pathology|December 29, 2000
Apolipoprotein H, a new mediator in the inflammatory changes ensuring in jeopardised human myocardiumH W Niessen, W K Lagrand, H J Rensink, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|July 1, 1996
Increased numbers of granzyme-B-expressing cytotoxic T-lymphocytes in the small intestine of HIV-infected patientsF Snijders, P C Wever, S A Danner, et al.
The Journal of Biological Chemistry|August 5, 1989
Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor)J H Nuijens, C C Huijbregts, A J Eerenberg-Belmer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Pro- and non-coagulant forms of non-cell-bound tissue factor in vivoK N Sturk-Maquelin, R Nieuwland, F P H T M Romijn, et al.
Agents and Actions. Supplements|January 1, 1992
Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patientsM Levi, C E Hack, J P de Boer, et al.
British Journal of Haematology|February 15, 2002
Complement activation plays a key role in the side-effects of rituximab treatmentL E van der Kolk, A J Grillo-López, J W Baars, et al.
Blood|December 15, 1990
Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathwaysS J van Deventer, H R Büller, J W ten Cate, et al.
British Journal of Haematology|May 1, 1986
Chronic idiopathic and secondary neutropenia: clinical and serological investigationsJ P van der Veen, C E Hack, C P Engelfriet, et al.
Pageof 37